newsfilter
← Latest News
GlobeNewswire·

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on